These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2033190)

  • 1. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias.
    Marchlinski FE; Buxton AE; Vassallo JA; Waxman HL; Cassidy DM; Doherty JU; Josephson ME
    J Am Coll Cardiol; 1984 Dec; 4(6):1247-54. PubMed ID: 6209319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
    Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
    Rials SJ; Britchkow D; Marinchak RA; Kowey PR
    Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms.
    Callans DJ; Marchlinski FE
    J Am Coll Cardiol; 1992 Jan; 19(1):111-7. PubMed ID: 1729321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of combination therapy with mexiletine and procainamide in patients with inducible sustained ventricular tachycardia refractory to intravenous procainamide.
    Widerhorn J; Sager PT; Rahimtoola SH; Bhandari AK
    Pacing Clin Electrophysiol; 1991 Mar; 14(3):420-6. PubMed ID: 1708872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide.
    Somberg JC; Tepper D; Sacher H; Schwarz J
    Am Heart J; 1987 Jul; 114(1 Pt 1):18-25. PubMed ID: 3111236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
    Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
    Pires LA; Wagshal AB; Greene TO; Mittleman RS; Huang SK
    Am J Cardiol; 1993 Oct; 72(12):908-10. PubMed ID: 8105674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procainamide in the induction and perpetuation of ventricular tachycardia in man.
    Kang PS; Gomes JA; El-Sherif N
    Pacing Clin Electrophysiol; 1982 May; 5(3):311-22. PubMed ID: 6179048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
    Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
    J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction.
    Iesaka Y; Aonuma K; Nitta J; Tokunaga T; Fujiwara H; Hiraoka M
    Jpn Circ J; 1988 Mar; 52(3):262-71. PubMed ID: 3373718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
    Rae AP; Sokoloff NM; Webb CR; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study.
    Kuchar DL; Rottman J; Berger E; Freeman CS; Garan H; Ruskin JN
    J Am Coll Cardiol; 1988 Oct; 12(4):982-8. PubMed ID: 3047198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
    Holzberger PT; Greenberg ML; Paicopolis MC; Ozahowski TP; Ho PC; O'Connor GT
    Am Heart J; 1998 Jul; 136(1):49-56. PubMed ID: 9665218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
    Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
    Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
    Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M
    Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.